Ad www.ProStocks.com
FREE Account Opening + No Clearing Fees + Rs 999 API Access
|
|
Incorporated in 2009, Vadivarhe Speciality Chemicals Ltd (VSCL) is primarily engaged in manufacturing of Speciality chemicals, Active Pharmaceutical ingredients, intermediate and personal care ingredients.
It is a a globally active, Indian chemical producer, focused on organic chemicals and custom synthesis. It has entered into an agreement with Enaltec Labs Pvt Ltd in December 2012 to manufacture API products for them for a period of 10 years based on the material and specification provided by them. The company has also entered into an agreement with Zenvision Pharma LLP for offering its manufacturing facility on Loan and License basis. Some of its major clients are Glaxo Smithkline Pharmaceuticals Ltd, Fine Organics Ltd UK, Chem-Impex International INC, D C Fine Chemicals, USV Ltd, Lupin Ltd, Mankind Pharma Limited, Himedia Laboratories Pvt. Ltd., Hetero Labs Ltd & many others in the Domestic and International sector.
The promoters of the company are:
1. Mr. Sunil Haripant Pophhale
The object of the issue are to:
1. To Meet Working Capital Requirement
2. General Corporate Purpose
3. To Meet the Issue Expenses
| IPO Opening Date | May 22, 2017 |
| IPO Closing Date | May 25, 2017 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹42 per equity share |
| Market Lot | 3000 Shares |
| Min Order Quantity | 3000 Shares |
| Listing At | NSE SME |
| Issue Size | 3,444,000 Eq Shares of ₹10 (aggregating up to ₹14.46 Cr) |
The Vadivarhe Speciality IPO market lot size is 3000 shares. A retail-individual investor can apply for up to 1 lots (3000 shares or ₹126,000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 3000 | ₹126,000 |
| Maximum | 1 | 3000 | ₹126,000 |
Investors may consider investment from short to long term in this reasonably priced issue of Vadivarhe Speciality NSE SME IPO. Read detail review...
The Vadivarhe Speciality IPO is subscribed times on May 25, 2017 5:00:00 PM. The public issue subscribed times in the retail category, times in the QIB category, and times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|
| Listing Date | Friday, June 2, 2017 |
| BSE Script Code | |
| NSE Symbol | VSCL |
| Listing In | |
| ISIN | INE551Q01028 |
| IPO Price | ₹42 per equity share |
| Face Value | ₹10 per equity share |
|
|
Vadivarhe Speciality Chemicals Ltd
Gat No. 204,
Vadivarhe,
Igatpuri, Maharashtra - 422403
Phone: +91-2553-282200
Email: cs@vscl.co.in
Website: http://www.vscl.net.in
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email:
Website: http://www.bigshareonline.com
Lead Manager Reports
Vadivarhe Speciality IPO is a SME IPO of 3,444,000 equity shares of the face value of ₹10 aggregating up to ₹14.46 Crores. The issue is priced at ₹42 per equity share. The minimum order quantity is 3000 Shares.
The IPO opens on May 22, 2017, and closes on May 25, 2017.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
The Vadivarhe Speciality IPO opens on May 22, 2017 and closes on May 25, 2017.
Vadivarhe Speciality IPO lot size is 3000 Shares and the minimum order quantity is 3000 Shares.
You can apply in Vadivarhe Speciality IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Vadivarhe Speciality IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Vadivarhe Speciality IPO allotment status.
Top Contributor (400+ Posts, 300+ Likes)
Useful Articles
IPO Guru (2100+ Posts, 1600+ Likes)
New here. :) Any idea why the stock is dropping daily? Nothing seems to be wrong in news anywhere. I entered at 128. Am I screwed or is their hope?